Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych TopicsGeneral adult psychiatry — mood disorders

Psych · General adult psychiatry — mood disorders

Psychotic depression

Also known as Major depression with psychotic features · Delusional depression · Depressive episode with psychotic symptoms · MDD with mood-congruent psychotic features · MDD with mood-incongruent psychotic features · Psychotic major depressive disorder

Exam-exhaustive fellowship reference on major depression with psychotic features — DSM-5-TR/ICD-11 framing, mood-congruent vs incongruent content, elevated suicide risk, combination antidepressant plus antipsychotic evidence (STOP-PD, STOP-PD II, Spiker, Cochrane), ECT, differentials from schizophrenia-spectrum and organic psychosis, metabolic monitoring, and maintenance after remission. FRANZCP-primary, globally tagged.

high18 referencesUpdated 25 July 202612 min readVerification in progress

Practise this topic

  • 10 MCQs

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • Active suicidal intent, plan, command hallucinations, or delusional drivers of self-harm (guilt, deserved death, nihilism) — escalate care intensity immediately
  • Food or fluid refusal, severe psychomotor retardation, mutism, or catatonic signs — urgent medical support and early ECT pathway
  • Antidepressant monotherapy left as 'the plan' for established psychotic depression — treat both poles (AD+AP or ECT)
  • Missed organic differentials: delirium, autoimmune encephalitis, endocrine crisis, substance-induced psychosis
  • Missed bipolarity — prior mania/hypomania changes formulation and long-term mood stabilisation
  • Olanzapine/quetiapine metabolic harm unmonitored; abrupt antipsychotic withdrawal soon after combination-induced remission (relapse risk)
On this page
Study tools

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • Active suicidal intent, plan, command hallucinations, or delusional drivers of self-harm (guilt, deserved death, nihilism) — escalate care intensity immediately
  • Food or fluid refusal, severe psychomotor retardation, mutism, or catatonic signs — urgent medical support and early ECT pathway
  • Antidepressant monotherapy left as 'the plan' for established psychotic depression — treat both poles (AD+AP or ECT)
  • Missed organic differentials: delirium, autoimmune encephalitis, endocrine crisis, substance-induced psychosis
  • Missed bipolarity — prior mania/hypomania changes formulation and long-term mood stabilisation
  • Olanzapine/quetiapine metabolic harm unmonitored; abrupt antipsychotic withdrawal soon after combination-induced remission (relapse risk)
The one-line answer

Psychotic depression is a major depressive episode plus delusions or hallucinations, and it needs both poles treated — antidepressant with antipsychotic (STOP-PD: sertraline plus olanzapine beat olanzapine alone) or ECT when severity, suicide risk, food refusal or catatonia will not wait. Never leave it on antidepressant monotherapy, and think hard before stopping the antipsychotic after remission (STOP-PD II).[1][2][11][12]

Meet the patient

A 68-year-old retired accountant has not eaten for three days. She is convinced she has bankrupted her family, that the pension office is preparing charges, and that her bowel has stopped working and is rotting inside her.[10][12]

Her GP started sertraline six weeks ago. Nobody asked about the delusions, because she never volunteered them and she is very polite.[9][12]

She is slowed, quiet, and rated "settled" on the last nursing shift. That word is the most dangerous thing in her file.[10]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References18ShowHide
  1. [1]Meyers BS, Flint AJ, Rothschild AJ, Mulsant BH, Whyte EM, Peasley-Miklus C, et al. A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD) Arch Gen Psychiatry, 2009.PMID 19652123
  2. [2]Flint AJ, Meyers BS, Rothschild AJ, Whyte EM, Alexopoulos GS, Rudorfer MV, et al. Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial JAMA, 2019.PMID 31429896
  3. [3]Kruizinga J, Liemburg E, Burger H, Cipriani A, Geddes J, Robertson L, et al. Pharmacological treatment for psychotic depression Cochrane Database Syst Rev, 2021.PMID 34875106
  4. [4]Wijkstra J, Lijmer J, Burger H, Cipriani A, Geddes J, Nolen WA Pharmacological treatment for psychotic depression Cochrane Database Syst Rev, 2015.PMID 26225902
  5. [5]Spiker DG, Weiss JC, Dealy RS, Griffin SJ, Hanin I, Neil JF, et al. The pharmacological treatment of delusional depression Am J Psychiatry, 1985.PMID 3883815
  6. [6]Rothschild AJ, Williamson DJ, Tohen MF, Schatzberg A, Andersen SW, Van Campen LE, et al. A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features J Clin Psychopharmacol, 2004.PMID 15232326
  7. [7]Wijkstra J, Burger H, van den Broek WW, Birkenhäger TK, Janzing JG, Boks MP, et al. Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine Acta Psychiatr Scand, 2010.PMID 19694628
  8. [8]Farahani A, Correll CU Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment J Clin Psychiatry, 2012.PMID 22579147
  9. [9]Ohayon MM, Schatzberg AF Prevalence of depressive episodes with psychotic features in the general population Am J Psychiatry, 2002.PMID 12411219
  10. [10]Gournellis R, Tournikioti K, Touloumi G, Thomadakis C, Michalopoulou PG, Christodoulou C, et al. Psychotic (delusional) depression and completed suicide: a systematic review and meta-analysis Ann Gen Psychiatry, 2018.PMID 30258483
  11. [11]UK ECT Review Group Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis Lancet, 2003.PMID 12642045
  12. [12]Malhi GS, Bell E, Bassett D, Boyce P, Bryant R, Hazell P, et al. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders Aust N Z J Psychiatry, 2021.PMID 33353391
  13. [13]Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments Can J Psychiatry, 2016.PMID 27486148
  14. [14]Kroenke K, Spitzer RL, Williams JB The PHQ-9: validity of a brief depression severity measure J Gen Intern Med, 2001.PMID 11556941
  15. [15]Keller J, Flores B, Gomez RG, Solvason HB, Kenna H, Williams GH, et al. Cortisol circadian rhythm alterations in psychotic major depression Biol Psychiatry, 2006.PMID 16458262
  16. [16]Schatzberg AF Anna-Monika Award Lecture, DGPPN Kongress, 2013: the role of the hypothalamic-pituitary-adrenal (HPA) axis in the pathogenesis of psychotic major depression World J Biol Psychiatry, 2015.PMID 24933348
  17. [17]Nelson JC, Papakostas GI Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials Am J Psychiatry, 2009.PMID 19687129
  18. [18]Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report Am J Psychiatry, 2006.PMID 17074942

Test yourself

Practise what you just read

  • 10 MCQs
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousPersistent depressive disorder (dysthymia)General adult psychiatry — mood disordersNextSeasonal and atypical depressionGeneral adult psychiatry — mood disorders